Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,165.75, giving the company a market capitalization of 1.1T. It carries a P/E multiple of 39.18 and pays a dividend yield of 0.58%.
On 2026-09-21, Eli Lilly(LLY) stock traded between a low of $1,134.64 and a high of $1,170.90. Shares are currently priced at $1,165.75, which is +2.7% above the low and -0.4% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.48M, compared to an average daily volume of 2.24M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
...
Eli Lilly (NVO) CEO David Ricks said he is optimistic that the drugmaker's oral weight loss pill Foundayo (orforglipron) will continue to increase its market sh...
Key Points Eli Lilly's stock is having an off year by its standards. The last time it didn't generate at least a double-digit return for its shareholders was...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly’s (LLY) stock is up about 2% on the afternoon of Sept. 21 after the company provided an update on sales of its weight-loss pill called “Foundayo.” In...
Eli Lilly received full U.S. FDA approval for Inluriyo, an oral estrogen receptor antagonist, in combination with Verzenio for adults with ER+, HER2–, ESR1-muta...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study A Single-ascending and Multiple-ascending Dose Study of LY3971297 te...
NVIDIA and Eli Lilly both shattered expectations this quarter, but picking the better stock for the next decade means choosing between two very different growth...
Shares of Eli Lilly (LLY) are trending higher after rival Novo (NVO) outlined a new growth strategy that failed to impress investors or analysts. LLY stock was...
Shares in Danish obesity drugmaker Novo (NVO) fell by 7% to around $40 on Monday morning, despite the company’s success in its late-stage Reimagine 5 trial. The...
Investing Novo Nordisk Falls 7% as Post-Wegovy Growth Plan Fails to Ease Competition Fears; Eli Lilly Slips, Viking Therapeutics Edges Higher Novo Nordisk took...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.